banner
Farnesyl transferase inhibitor, FTI 277, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM511

Farnesyl transferase inhibitor, FTI 277, Purity ≥98%

Synonym: 170006-73-2; FTI-277; FTI277; FTI-277 trifluoroacetate; Methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoate; Farnesyl transferase inhibitor

  • CAS Number: 170006-73-2
  • Compound CID: 3005532
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
FTI 277 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting farnesyl transferase. The molecular weight of the compound is 561.64, and its molecular formula is C22H29N3O3S2·C2HF3O2.
Molecular Weight
561.64
Molecular Formula
C22H29N3O3S2·C2HF3O2
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
FTI 277 displays the significant potential to act as an effective farnesyltransferase inhibitor, similar to lonafarnib, and blocks the farnesylation of proteins involved in oncogenic signaling.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0